FDA approved first cellbBased gene therapy to treat adult and pediatric patients with Beta-thalassemia
On Aug. 17, 2022, the U.S. Food and Drug Administration approved Zynteglo (betibeglogene autotemcel) developed by bluebird bio,…
On Aug. 17, 2022, the U.S. Food and Drug Administration approved Zynteglo (betibeglogene autotemcel) developed by bluebird bio,…
On Aug. 16, 2022, UNICEF announced that it had awarded a contract for the first ever supply of…
On Aug. 15, 2022, Roche announced the launch of the Elecsysï¾® IGRA SARS-CoV-2 test in countries that accept…
On Aug. 15, 2022, the U.S. Department of Health and Human Services announced that was making up to…
On Aug. 12, 2022, a group of global experts convened by WHO agreed on new names for monkeypox…
On Aug. 9, 2022, the U.S. Food and Drug Administration issued an emergency use authorization for the JYNNEOS…
On Aug. 9, 2022, the the Department of Health and Human Services (HHS) announced it had determined that…
On Aug. 5, 2022, researchers from the National Institutes of Health announced that they had developed a three-dimensional…
On Aug. 4, 2022, the U.S. Department of Health and Human Services declared the ongoing spread of monkeypox…
On Jul. 30, 2022, scientists announced they had sequenced the genome of a 6,000-year-old Citrullus seeds that revealed…
On Jul. 28, 2022, the Allen Institute announced a newly released dataset of 1.2M cells from brain donors…
On Jul. 27, 2022, BD (Becton, Dickinson) announced their newly developed molecular polymerase chain reaction (PCR) test for…
On Jul. 27, 2022, Pfizer and BioNTech announced that the companies had initiated a randomized, active-controlled, observer-blind, Phase…
On Jul. 22, 2022, Gilead Sciences announced that the Committee for Medicinal Products for Human Use (CHMP) of…
On Jul. 19, 2022, Gilead Sciences and the European Commission announced a new joint procurement agreement (JPA) that…
On Jul. 19, 2022, Yale scientists announced they had developed a novel Omicron-specific mRNA vaccine that offers superior…
On Jul. 19, 2022, the NIH announced that although COVID-19 booster vaccinations in adults elicit high levels of…
On Jul. 17, 2022, Ghana announced the preliminary finding of two cases of Marburg virus disease and if…
On Jul. 15, 2022, The largest sustained decline in childhood vaccinations in approximately 30 years has been recorded…
On Jul 14. 2022, Aegis Sciences announced it is was authorized to begin testing for monkeypox using the…
On Jul. 13, 2022, Quest Diagnostics announced that it had announced the nationwide availability* of the company’s lab-developed…
On Jul 13. 2022, Quest Diagnostics announced the nationwide availability of the company’s lab-developed molecular diagnostic test to…
On Jul. 8, 2022, Pfizer and BioNTech announced that the companies had submitted a variation to the European…
On Jul. 6, 2022, LabCorp announced that it had begun testing for monkeypox using the U.S. Centers for…
On Jul. 5, 2022, Tgen and Northern Arizona University announced that a research team found that the vaccine…
On Jul. 5, 2022, the National Institutes of Health released a study that described the immune response triggered…
On Jun. 30, 2022, Pfizer and BioNTech announced a vaccine supply agreement with the U.S. government to support…
Play the COVID-19 Wheel of Fortune and see how lucky you are! You have two wheels to choose…
On Jun. 24 2022, Pfizer and BioNTech announced positive data evaluating the safety, tolerability, and immunogenicity of two…
On Jun. 24, 2022, Emergent BioSolutions announced that the U.S. Food and Drug Administration accepted for review the…